| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2312839C Compositions for nasal administration |
| 01/15/2008 | CA2272971C Quinone derivatives for treating or preventing diseases associated with iron overload |
| 01/15/2008 | CA2169191C Neural regeneration using human bone morphogenetic proteins |
| 01/10/2008 | WO2008006099A2 Treatment of psychiatric disorders |
| 01/10/2008 | WO2008005956A2 Pyrrolotriazine kinase inhibitors |
| 01/10/2008 | WO2008005908A2 Pyridoimidazole derivatives |
| 01/10/2008 | WO2008005036A1 Pharmaceutical compositions of memantine |
| 01/10/2008 | WO2008004908A1 Nootropic medicinal agent |
| 01/10/2008 | WO2008004716A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 01/10/2008 | WO2008004698A2 Pyrazolo [1, 5-a] pyrimidine compounds as cb1 receptor antagonist |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004191A2 Process for the preparation of enantiomerically pure salts of n-methyl-3- ( 1-naphthaleneoxy) -3- (2-thienyl) propanamine |
| 01/10/2008 | WO2008004117A1 Selective azole pde10a inhibitor compounds |
| 01/10/2008 | WO2008004067A2 Alpha-2-delta-1 selective compounds for disorders of the nervous system |
| 01/10/2008 | WO2008004013A2 Medicament for the enhancement of cognitive function and neuroprotection |
| 01/10/2008 | WO2008003856A1 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | WO2008003855A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | WO2008003736A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | WO2008003697A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 01/10/2008 | WO2008003667A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 01/10/2008 | WO2008003511A1 Use of aminothiazole derivative compounds, pharmaceutical compositions thereof, in the treatment of diseases characterized by abnormal repression of gene transcription, particularly huntington's disease |
| 01/10/2008 | WO2008003452A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 01/10/2008 | WO2008003185A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 01/10/2008 | WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2007122591A3 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists |
| 01/10/2008 | WO2007121921A3 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/10/2008 | WO2007117995A3 Kinase inhibitors |
| 01/10/2008 | WO2007110047B1 TERGURIDE/PROTERGURIDE FOR THE TREATMENT OF CHRONIC PAIN (e.g. MIGRAINE) |
| 01/10/2008 | WO2007106685A3 Targets for depression and bipolar disorders |
| 01/10/2008 | WO2007103432A9 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders |
| 01/10/2008 | WO2007081910A3 Compositions and methods of treatment using modulators of motonueron diseases |
| 01/10/2008 | WO2007006922A8 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers |
| 01/10/2008 | WO2006098834A8 Crystalline forms of ziprasidone mesylate |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009624 Heteroaryl carboxamides |
| 01/10/2008 | US20080009546 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders |
| 01/10/2008 | US20080009544 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors |
| 01/10/2008 | US20080009542 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |
| 01/10/2008 | US20080009541 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration |
| 01/10/2008 | US20080009539 Azo Compounds and Process for Production Thereof |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009521 Aryl Piperidine Amides |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009518 5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists |
| 01/10/2008 | US20080009516 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 01/10/2008 | US20080009514 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | US20080009513 Therapeutic agents |
| 01/10/2008 | US20080009505 Theanine derivatives, uses thereof and processes for the manufacture thereof |
| 01/10/2008 | US20080009491 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 01/10/2008 | US20080009481 Process For Making Form I Of Olanzapine |
| 01/10/2008 | US20080009480 CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
| 01/10/2008 | US20080009479 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands |
| 01/10/2008 | US20080009478 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| 01/10/2008 | US20080009477 Arylalkyl Ureas As Cb1 Antagonists |
| 01/10/2008 | US20080009475 Pharmacological treatment of cognitive impairment |
| 01/10/2008 | US20080009469 Medicament for Threapeutic Treating of Pain |
| 01/10/2008 | US20080009467 Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| 01/10/2008 | US20080009465 Novel glucokinase activators and methods of using same |
| 01/10/2008 | US20080009461 Therapeutic compounds |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009448 Peptide Derivative |
| 01/10/2008 | US20080008754 Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol |
| 01/10/2008 | US20080008748 Method for treating pain using a substituted 2-aminotetralin compound |
| 01/10/2008 | US20080008746 Compositions and method for treatment of Attention Deficit Disorder and Attention Deficit/Hyperactivity Disorder with methylphenidate |
| 01/10/2008 | US20080008745 Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles |
| 01/10/2008 | US20080008743 Orally Dissolving Formulations of Memantine |
| 01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
| 01/10/2008 | US20080008692 Methods and compositions for altering cell function |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008680 pure mutant Interleukin-15 polypeptide; immunosuppressant; immunotherapy |
| 01/10/2008 | US20080008659 Oral dosage form comprising an antimisuse system |
| 01/10/2008 | CA2659060A1 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 01/10/2008 | CA2656905A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | CA2656549A1 Medicament for the enhancement of cognitive function and neuroprotection |
| 01/10/2008 | CA2656183A1 Modulators of muscarinic receptors |
| 01/10/2008 | CA2656170A1 Infant formulas for early brain development |
| 01/10/2008 | CA2656128A1 Process for the preparation of enantiomerically pure salts of n-methyl-3(1-naphthaleneoxy)-3-(2-thienyl)propanamine |
| 01/10/2008 | CA2656045A1 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | CA2655713A1 Derivatives of imidazo[1,2-.alpha.]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | CA2655680A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 01/10/2008 | CA2655675A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 01/10/2008 | CA2655552A1 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | CA2654666A1 Pharmaceutical compositions |
| 01/10/2008 | CA2654523A1 Pharmaceutical compositions of memantine |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1876169A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |
| 01/09/2008 | EP1875923A2 Use of fractalkine for the production of a neuroprotector drug against cell death |
| 01/09/2008 | EP1875921A1 Dpp4 inhibitor and pharmaceutical application thereof |
| 01/09/2008 | EP1875912A1 Agent for treating involuntary movement |
| 01/09/2008 | EP1875902A1 Sedative effect-providing agent and sedative fragrance composition containing the same |
| 01/09/2008 | EP1875901A1 Propofol-containing fat emulsion |
| 01/09/2008 | EP1875898A2 Transdermal patch for administering fentanyl |
| 01/09/2008 | EP1874783A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 01/09/2008 | EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders |
| 01/09/2008 | EP1874756A1 Chromane and chromene derivatives and uses thereof |
| 01/09/2008 | EP1874755A2 Benzothiophene hydroxamic acid derivatives |